CARR vs KALV · P/E 43, rev $21.75B vs rev $13.7M
Carrier Global Corp (CARR) versus Kalvista Pharmaceuticals Inc (KALV) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. KALV currently screens at market cap $1.44B.
Not investment advice. Open the CARR and KALV stock pages for the full models.
Not investment advice.